This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jing, C. Articles by Ke, Y. Search for Related Content PubMed PubMed Citation Articles by Jing, C. Articles by Ke, Y.

Identification of the Messenger RNA for Human Cutaneous Fatty Acid-binding Protein as a Metastasis Inducer¹

Molecular Pathology Laboratory, Department of Pathology [C. J., C. B., C. S. F., P. H. S., Y. K.] and Department of Haematology, Faculty of Medicine [H. C.], School of Biological Sciences [P. S. R.], University of Liverpool, Liverpool L69 3BX, United Kingdom, and Department of Biochemistry, Niigata University School of Medicine, Niigata 951, Japan [H. F., T. O.]

Using our recently developed systematic differential display and complete comparison of gene expression approaches combined with other methods, we have identified a large number of mRNAs that are expressed differentially between benign and malignant human cells. One such mRNA that is common to prostate and breast carcinoma cell lines encodes the human cutaneous fatty acid-binding protein (C-FABP). Northern and slot blot analyses confirm that the expression levels of C-FABP mRNA in the malignant prostate and breast carcinoma cell lines are 4.9 ± 0.9- to 16.9 ± 2.1-fold higher than those expressed in the benign cell lines. A similar difference between the benign and malignant cell lines was also detected at the protein level. In situ hybridization experiments have detected overexpression of the mRNA for C-FABP in human prostate carcinoma tissues. Transfection of a C-FABP expression construct into the benign, nonmetastatic rat mammary epithelial cell line Rama 37 and inoculation of the C-FABP expression transfectants into syngeneic Wistar-Furth rats produce a significant number (P < 0.05) of animals with metastases (6 of 26 animals), whereas the control transfectants generated by the vector alone yield no such metastases. Measurements of mRNA and protein levels with Northern and Western blotting show that C-FABP is not expressed in the control transfectant cells produced by the vector alone but is highly expressed in the pool of C-FABP transfectants and the sublines established from their metastases. Immunocytochemical staining with antibodies to C-FABP shows that C-FABP is not expressed in the primary tumors developed from the control transfectants that have failed to metastasize, but it is expressed in both the primary tumors developed from the C-FABP transfectants and their metastases. Reinoculation of the sublines established from metastases in syngeneic rats has produced a higher proportion (50%) of animals (7 of 14 animals) with metastases than that obtained in the first-round inoculations, indicating that the metastatic clones have been preferentially selected from the original pool of metastatic and nonmetastatic transfectant clones. These results have demonstrated that elevated expression of C-FABP can induce metastasis and that metastatic capability has been transferred in a genetically dominated manner in this Rama 37 model. Thus, we suggest that C-FABP is a metastasis-inducing gene, and under suitable conditions, it may induce metastasis of some human cancers.

This article has been cited by other articles:

				T. Ohmachi, H. Inoue, K. Mimori, F. Tanaka, A. Sasaki, T. Kanda, H. Fujii, K. Yanaga, and M. Mori Fatty Acid Binding Protein 6 Is Overexpressed in Colorectal Cancer Clin. Cancer Res., September 1, 2006; 12(17): 5090 - 5095. [Abstract] [Full Text] [PDF]

				A. Bee, Y. Ke, S. Forootan, K. Lin, C. Beesley, S. E. Forrest, and C. S. Foster Ribosomal protein l19 is a prognostic marker for human prostate cancer. Clin. Cancer Res., April 1, 2006; 12(7): 2061 - 2065. [Abstract] [Full Text] [PDF]

				D. Liu, P. S. Rudland, D. R. Sibson, A. Platt-Higgins, and R. Barraclough Human Homologue of Cement Gland Protein, a Novel Metastasis Inducer Associated with Breast Carcinomas Cancer Res., May 1, 2005; 65(9): 3796 - 3805. [Abstract] [Full Text] [PDF]

				C. Jing, M. A. El-Ghany, C. Beesley, C. S. Foster, P. S. Rudland, P. Smith, and Y. Ke Tazarotene-Induced Gene 1 (TIG1) Expression in Prostate Carcinomas and Its Relationship to Tumorigenicity J Natl Cancer Inst, April 3, 2002; 94(7): 482 - 490. [Abstract] [Full Text] [PDF]

				C. Jing, C. Beesley, C. S. Foster, H. Chen, P. S. Rudland, D. C. West, H. Fujii, P. H. Smith, and Y. Ke Human Cutaneous Fatty Acid-binding Protein Induces Metastasis by Up-Regulating the Expression of Vascular Endothelial Growth Factor Gene in Rat Rama 37 Model Cells Cancer Res., June 1, 2001; 61(11): 4357 - 4364. [Abstract] [Full Text] [PDF]

				R. Das, R. Hammamieh, R. Neill, M. Melhem, and M. Jett Expression Pattern of Fatty Acid-binding Proteins in Human Normal and Cancer Prostate Cells and Tissues Clin. Cancer Res., June 1, 2001; 7(6): 1706 - 1715. [Abstract] [Full Text] [PDF]